Scientific articles

Mathieu EPARDAUD, co-founder, and scientific consultant at Lovaltech, is the author of the article “Advantages and challenges of anti-COVID nsal vaccination: the promises of a French approach“ published on December 19, 2022, in the French version and on February 13, 2023, in the English version on the Conversion.

In this article, Mathieu describes the specific features of the French vaccine against Covid 19, in terms of its administration, mode of operation and manufacturing technique. Mathieu also talks about the next steps in the development of the nasal vaccine, and the challenges facing the Lovaltech team. In particular, the development of a spray system compatible with vaccination. Two methods are presented in this article: an in vitro method and an in vivo method.

French version: https://theconversation.com/atouts-et-defis-de-la-vaccination-nasale-anti-covid-les-promesses-dune-approche-francaise-196529

English version: https://theconversation.com/advantages-and-challenges-of-anti-covid-nasal-vaccination-the-promises-of-a-french-approach-197746